News

What's New

  • Complimentary media registration is available for upcoming NCCN 2021 Virtual Congress: Hematologic Malignancies™ Oct. 14-16. View agenda.
  • New research in JNCCN asks if too many Phase III cancer trials are set up to fail. Read more.

Stay up-to-date on NCCN by subscribing to our eBulletin newsletter here.

Contact

Rachel Darwin, Senior Manager, Public Relations

darwin@nccn.org, 267-622-6624

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine.

Multi-disciplinary subject matter experts from across the NCCN Guidelines® panels are available for interviews.

Patients and caregivers seeking information can visit Patient Resources or email  patientinformation@nccn.org. Email usersupport@nccn.org for technical support.
NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Guidelines. For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content (visit Licensing and Permissions or email  PermissionRequest@nccn.org).

Featured Stories


NCCN and American Cancer Society: Cancer Won’t Wait And Neither Should You
World Cancer Day: Children Ask Leaders: What does Cervical Cancer Elimination mean?